ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,016, issued on Nov. 4, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).
"Plasma kallikrein binding proteins" was invented by Daniel J. Sexton (Melrose, Mass.) and Malini Viswanathan (Acton, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Plasma kallikrein binding proteins and methods of using such proteins are described."
The patent was filed on Oct. 4, 2022, under Application No. 17/937,795.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12460016&OS=12460016&RS=...